Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Autoimmunity Reviews is Scopus-indexed (Q1, CiteScore 15.8), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 1568-9972Verify ISSN ↗1873-0183Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: About US$4,730 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 20 / 234 | 91st | Q1 |
| Immunology | 24 / 243 | 90th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2002–present, best quartile Q1, CiteScore 15.8.
Autoimmunity Reviews is Q1 in Immunology and Allergy (rank 20 of 234) and Q1 in Immunology (rank 24 of 243), by CiteScore 2025.
Autoimmunity Reviews is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 15.8, which places it in quartile Q1 at the 91st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.669, quartile Q1, with an H-index of 170.
The publisher lists an article processing charge of about US$4,730 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Autoimmunity Reviews is published by Elsevier B.V. Its print ISSN is 1568-9972 and its online ISSN is 1873-0183.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Autoimmunity Reviews has an h-index of 195 and a 2-year mean of 7.77 citations per paper (OpenAlex). Its Scopus CiteScore is 15.8, quartile Q1. On 2-year citations it ranks #22 of 231 Scopus journals in Immunology and Allergy.
Autoimmunity Reviews published 165 papers in 2025; its busiest recent year was 2020 with 204. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (27.8%), Italy (13.9%) and United States (6.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (1.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.